ALK-Abelló A/S (4AJ0)
FSX
Real-time Data
06:00 AM
Day's Range
28.5252 wk Range
26.22Overview - 4AJ0 - ALK-Abelló A/S
Key Statistics
Valuation
Enterprise Value
663.30M
P/E (Trailing)
34.48
PEG Ratio
1.37
Price / Sales (TTM)
0.91
Price / Book
6.75
EV / EBITDA
2.36
Profitability
Gross Margin
69.33%
Profit Margin
19.85%
Operating Margin
24.79%
Return on Assets
12.74%
Return on Equity
21.20%
Ownership
Shares Outstanding
221.58M
Float
132.12M
Held by Insiders
0.00%
Held by Institutions
63.94%
Price stats
Beta
0.70
50-Day Avg
31.56
200-Day Avg
30.66
Dividends
Payout Ratio
26.22%
Market Cap - 4AJ0 - ALK-Abelló A/S
Peers - 4AJ0 - ALK-Abelló A/S
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 4AJ0FSXALK-Abelló A/S6.26BMarket Cap+2.33%52-week change34.91P/E (Trailing)19.85%Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)29.78%Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)32.26%Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)32.26%Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)-141.42%Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)0.00%Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)10.69%Profit Margin
Profile Summary - 4AJ0 - ALK-Abelló A/S
About
ALK-Abelló A/S is a Denmark-based global pharmaceutical company specializing in the development, manufacturing, and marketing of products for allergy prevention, diagnosis, and treatment. Founded in 1923 and headquartered in Hørsholm, it pioneered allergy immunotherapy, offering unique vaccination therapies in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
